If Drug Distributors Can Coordinate Without Anti-Trust Concerns During The Coronavirus Pandemic, What About Generic Manufacturers?

 
• By Derrick Gingery

Experts and stakeholders suggest it may help avoid drug shortages, but also indicate the interaction, which in normal times would raise anti-trust concerns, may not be needed, even to fight coronavirus.

Coronavirus dollar bill
Coordinated efforts among generic manufacturers may help prevent drug shortages, although under normal conditions such a move would raise anti-trust concerns. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics